Free Trial
→ NEW LAW: Congress Approves Setup For Digital Dollar? (From Goldco Precious Metals) (Ad)tc pixel

EKF Diagnostics (LON:EKF) Stock Price Down 7% - Here's What Happened

Written by MarketBeat
October 25, 2025
EKF Diagnostics logo with Medical background

Key Points

  • EKF Diagnostics Holdings plc shares experienced a 7% decrease during trading, reaching a low of GBX 23.60 and last trading at GBX 26.
  • The trading volume surged by 404% to approximately 2,281,890 shares, compared to the average daily volume.
  • The company recently reported an EPS of GBX 0.43 for the quarter, with predictions for the current fiscal year EPS at approximately 2.30.
  • Five stocks to consider instead of EKF Diagnostics.

EKF Diagnostics Holdings plc (LON:EKF - Get Free Report) shares were down 7% during trading on Saturday . The company traded as low as GBX 23.60 ($0.31) and last traded at GBX 26 ($0.35). Approximately 2,281,890 shares traded hands during trading, an increase of 404% from the average daily volume of 453,091 shares. The stock had previously closed at GBX 27.95 ($0.37).

EKF Diagnostics Price Performance

The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.77 and a current ratio of 4.60. The business has a 50 day moving average price of GBX 29.18 and a 200-day moving average price of GBX 26.59. The company has a market capitalization of £116.76 million, a price-to-earnings ratio of 19.26 and a beta of 0.57.

EKF Diagnostics (LON:EKF - Get Free Report) last released its earnings results on Tuesday, September 16th. The company reported GBX 0.43 EPS for the quarter. EKF Diagnostics had a return on equity of 7.03% and a net margin of 9.37%. Research analysts predict that EKF Diagnostics Holdings plc will post 2.2987842 EPS for the current fiscal year.

EKF Diagnostics Company Profile

(Get Free Report)

EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in EKF Diagnostics Right Now?

Before you consider EKF Diagnostics, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EKF Diagnostics wasn't on the list.

While EKF Diagnostics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover
Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.